InnovAge Holding Corp
NASDAQ:INNV
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.55
6.36
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
InnovAge Holding Corp
InnovAge Holding Corp
Accounts Receivables
InnovAge Holding Corp
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
InnovAge Holding Corp
NASDAQ:INNV
|
Accounts Receivables
$48.1m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Accounts Receivables
$2.3B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
4%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Accounts Receivables
$1.4B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
4%
|
|
|
CVS Health Corp
NYSE:CVS
|
Accounts Receivables
$9.9B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-1%
|
|
|
Cigna Corp
NYSE:CI
|
Accounts Receivables
$27.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Accounts Receivables
$2.2B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
1%
|
CAGR 10-Years
10%
|
|
InnovAge Holding Corp
Glance View
InnovAge Holding Corp. engages in the provision of a healthcare delivery platform. The company is headquartered in Denver, Colorado and currently employs 1,800 full-time employees. The company went IPO on 2021-03-04. The firm delivers its patient-centered care through the InnovAge Platform. InnovAge Platform is focused on frail, dual-eligible seniors, and it serve participants primarily through Program of All-inclusive Care for the Elderly (PACE). InnovAge Platform provides complete, coordinated healthcare to enable its frail, nursing home-eligible seniors to live independently in their homes and communities. The InnovAge Platform consists of Interdisciplinary Care Teams and community-based care delivery model. The firm's subsidiaries include TCO Intermediate Holdings, Inc., Total Community Options, Inc., InnovAge Investment Holdings, LLC, TCO Eastern Holdings, LLC, InnovAge Pennsylvania LIFE, LLC, InnovAge Virginia PACE Roanoke Valley, LLC, InnovAge Virginia PACE II, LLC, InnovAge Virginia PACE Charlottesville, LLC, Total Longterm Care Solutions, LLC, Total Longterm Care, Inc. and InnovAge Greater Colorado PACE-Loveland, LLC.
See Also
What is InnovAge Holding Corp's Accounts Receivables?
Accounts Receivables
48.1m
USD
Based on the financial report for Jun 30, 2024, InnovAge Holding Corp's Accounts Receivables amounts to 48.1m USD.
What is InnovAge Holding Corp's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
-1%
Over the last year, the Accounts Receivables growth was 98%. The average annual Accounts Receivables growth rates for InnovAge Holding Corp have been 14% over the past three years , -1% over the past five years .
You don't have any saved screeners yet
